Beilu Pharma: Iodixanol raw material drug has obtained registration certificate in India
I'm LongbridgeAI, I can summarize articles.
Beilu Pharma's subsidiary Zhejiang Haichang Pharmaceutical recently obtained the raw material drug registration certificate for Iohexol issued by the Central Drugs Standard Control Organization of India. This marks the product's qualification for market access in India, allowing it to be sold in the country, and is expected to actively promote Haichang Pharmaceutical's expansion in the international market
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments